Jan I. Heggdal
Bergen, 5021, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Phase I trial combining sulfasalazine and gamma knife radiosurgery for recurrent glioblastoma.
Journal: MethodsX
Published: January 28, 2026
The Styryl Benzoic Acid Derivative DC10 Potentiates Radiotherapy by Targeting the xCT-Glutathione Axis.
Journal: Frontiers in oncology
Published: October 01, 2021
A simple score to estimate the likelihood of pseudoprogression vs. recurrence following stereotactic radiosurgery for brain metastases: The Bergen Criteria.
Journal: Neuro-oncology advances
Published: July 10, 2020
Multimodal approach to assess tumour vasculature and potential treatment effect with DCE-US and DCE-MRI quantification in CWR22 prostate tumour xenografts.
Journal: Contrast media & molecular imaging
Published: December 12, 2014
Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion.
Journal: Oncogene
Published: July 11, 2014
Gamma knife surgery as monotherapy with clinically relevant doses prolongs survival in a human GBM xenograft model.
Journal: BioMed research international
Published: April 20, 2013
γ knife surgery versus reoperation for recurrent glioblastoma multiforme.
Journal: World neurosurgery
Published: November 18, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026